Go to AAD Home
Donate For Public and Patients Store Search
Go to AAD Home
Main menu
Membership
Meetings & Education
Practice management
Clinical & quality
Publications & apps
Career development
Advocacy
Back
Account
Pay dues
Member ID
Join the AAD
Member benefits
Find a member
AAD governance
Support AAD
Community Programs
AAD Help Center
2026 Annual Meeting
2026 Innovation Academy
Academy meetings archive
Professional education
Claim CME & view transcript
Upcoming events
Residents & medical students
Patient education materials
DataDerm
Coding Resource Center
MIPS & fee schedule
Teledermatology
EHR & health tech
Insurance & drugs
Compliance & practice scope
Managing your practice
Contact PM staff
Clinical guidelines
Quality measures
DataDerm
Quality & patient safety
Clinical Community
Clinical care resources
Position statements
JAAD
JAAD International
JAAD Case Reports
Dermatology World
DermWorld Insights & Inquiries
Derm Coding Consult
DermWorld Meeting News
Impact Report
Other publications
Academy Apps
Job board
Join or sell a practice
Burnout & wellness
Career launch
Diversity
Awards, grants, and scholarships
Leadership Institute
Volunteer opportunities
Ethics & professionalism
Take action
Advocacy priorities
State advocacy resources
Legislative Conference
Position statements
Promote the specialty
Key Contacts
Patient advocate resources
SkinPAC
Advocacy Update
Welcome!

Statement on the FDA Safety Briefing about Radiofrequency Microneedling Risks

Statement from Susan C. Taylor, MD, FAAD, President, American Academy of Dermatology

ROSEMONT, Ill. (Oct. 16, 2025) — The American Academy of Dermatology (AAD) is aware of the FDA’s recent safety communication regarding potential risks associated with certain uses of radiofrequency (RF) microneedling.  

Patient safety is the top priority for the AAD and its member dermatologists, who have the most extensive medical training to help avoid complications and ensure the best possible outcomes with all skin, hair, and nail procedures. 

While cosmetic treatments may appear simple, performing them safely requires an in-depth understanding of the structure and function of the skin. Board-certified dermatologists undergo rigorous medical education and specialized training in facial anatomy, including nerves and muscles. This advanced expertise allows them to minimize risks and effectively manage any complications that may arise.  

The Academy remains committed to ensuring safe, high-quality dermatologic care for all patients. Individuals considering cosmetic treatments are encouraged to consult a board-certified dermatologist to discuss their goals, treatment options, and expected outcomes. 

To find a board-certified dermatologist near you, visit aad.org/findaderm.  

# # #

Contact

Shelby Homiston, shomiston@aad.org

Media Relations, mediarelations@aad.org

About the AAD

Headquartered in Rosemont, Ill., the American Academy of Dermatology, founded in 1938, is the largest, most influential and most representative of all dermatologic associations. With a membership of more than 21,800 physicians worldwide, the AAD is committed to advancing the diagnosis and medical, surgical, and cosmetic treatment of the skin, hair, and nails; advocating high standards in clinical practice, education and research in dermatology; and supporting and enhancing patient care because skin, hair, and nail conditions can have a serious impact on your health and well-being. For more information, contact the AAD at (888) 462-DERM (3376) or aad.org. Follow @AADskin on  Facebook, TikTok, Pinterest, and YouTube, and @AADskin1 on Instagram.